Heparin, the world’s most widely used blood thinner, is used during procedures ranging from kidney dialysis to open heart surgery. Currently, heparin is derived from pig intestines, but scientists at Rensselaer Polytechnic Institute have discovered how to make it in the lab. They have also developed a path to a biomanufacturing process that could potentially revolutionize how the world gets its supply of this crucial medicine. 

Steve Eshiemogie, a doctoral student studying chemical and biological engineering at Rensselaer Polytechnic Institute, has been recognized as an honorable mention in the annual Cell Press Rising Black Scientists Awards for his essay “From village to lab: An African scientist’s quest for a sustainable future.” [MS1] More than 350 students across a range of scientific disciplines applied. 

Joan Llabre, Ph.D. '23, who received her doctorate in biomedical engineering from Rensselaer Polytechnic Institute this past fall and is now a postdoctoral researcher at the Institute, has won the Koerner Family Foundation Fellowship, which supports engineers pursuing careers in research. 

This year, Rensselaer Polytechnic Institute researchers will begin work on a radically new approach to treating and preventing genetic diseases such as Alzheimer’s.It’s thanks to a grant from the National Institutes of Health’s TARGETED Challenge, which funds scientific research on ways to deliver gene editing tools directly to cells in the human body. 

For the first time, researchers have used bacteria to “upcycle” waste polyethylene

A team led by scientists at Rensselaer Polytechnic Institute has 3D-printed hair follicles in human skin tissue cultured in the lab. This marks the first time researchers have used the technology to generate hair follicles, which play an important role in skin healing and function.

Intuit, Ecovative, Optum Labs, Nancy’s Specialty Foods, and Vicarious Visions, which was acquired by Blizzard Entertainment, all have something in common: they were founded by alumni of Rensselaer Polytechnic Institute. They are also previous William F. Glaser ’53 Entrepreneurs of the Year through Rensselaer’s Paul J. ’69 and Kathleen M. Severino Center for Technological Entrepreneurship.

Using artificial intelligence tools to analyze years of biomedical data, researchers at Rensselaer Polytechnic Institute have discovered a possible connection between sleep, gastrointestinal health, and two potentially harmful behaviors often associated with profound autism: self-injury and aggression. Their study is published in the Journal of Personalized Medicine.

From 10 a.m. until 4 p.m. on Saturday, October 28, Rensselaer Polytechnic Institute will host the Boston Regional Inorganic Colloquium (BRIC) at the Shirley Ann Jackson, Ph.D. Center for Biotechnology and Interdisciplinary Studies. The first BRIC was held in 2004 to connect inorganic chemists in academia and industry and to promote community and collaboration. BRIC has since expanded beyond Boston to include all of New England.

Rensselaer Polytechnic Institute’s Mattheos Koffas, Ph.D., Dorothy and Fred Chau ʼ71 Constellation Professor in Biocatalysis and Metabolic Engineering, has won the inaugural June Wispelwey Bio Leadership Fellowship. The fellowship provides a grant “to assist scientists and engineers in spearheading projects that may lead to important technical, business, or community advancements in the biological engineering field.”